MRNXDefiance Daily Target 2X Long MRNA ETF
Seeks daily investment results of 200% the daily percentage change in the share price of Moderna, Inc.
By Defiance ETFs LLC · Launched 2026
Annual Cost
1.31%
#5,752 of 6,040 · expensive
Fund Size
$2M
#5,597 of 6,040 · small
Return (1Y)
N/A
Track Record
7 months
#5,137 of 6,040 · young
Performance
Total-return NAV · USDGrowth of $10,000
$11,689+16.9%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityStrategy
Leveraged
Holdings
By weightConcentration
single-stock exposure — holdings shown are derivatives collateral, not the fund's position
TREASURY BILL
21.6%
N/A
5.5%
First American Government Obli
4.3%
N/A
2.3%
N/A
0.3%
N/A
-0.5%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
N/A
Max drawdown
-72.0%Severe
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- NYSE American, NYSE Arca
Full fund details
- Objective
- Seeks daily investment results of 200% the daily percentage change in the share price of Moderna, Inc.
- Strategy
- Actively managed ETF aiming for 200% of the daily percentage change in the share price of Moderna, Inc. through derivatives like swaps and options. Focused on the biotechnology industry, with daily rebalancing to maintain leverage.
- Inception date
- February 3, 2026
- Fund family
- Defiance ETFs LLC
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save MRNX to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-18